Replimune Group, Inc. (REPL) by event type
REPL moves most on analyst downgrades — a median of -1.62% at 30 minutes across 45 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the REPL overview →
How REPL reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,421 of 2,717 | 44 | -0.56% | 39% | -0.75% |
| Analyst downgrades 2,500 of 2,603 | 45 | -1.62% | 42% | -0.58% |
| Rating reiterations 3,400 of 3,522 | 50 | -0.75% | 32% | -0.90% |
| Price-target raises 1,760 of 1,790 | 17 | -0.68% | 35% | -1.72% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how REPL usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · REPL overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) | 1,452 | +0.01% | 51% |
| GENMARK DIAGNOSTICS (GNMK) | 1,451 | +0.06% | 51% |
| Altimmune, Inc. (ALT) | 1,424 | 0.00% | 48% |
| PerkinElmer, Inc. (PKI) | 1,409 | +0.11% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.